Response Evaluation Criteria in Solid Tumors
Evaluation of response from axitinib per response evaluation criteria in solid tumors versus Choi criteria in previously treated patients with metastatic renal cell carcinoma
9
<p>Clinical outcome of osteosarcoma and its correlation with programmed death-ligand 1 and T cell activation markers</p>
6
Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment
9
Use of Initial Modified RECIST Tumor Response Evaluation Criteria for Predicting Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization with Drug Eluting Beads
9
All trans retinoic acid (ATRA) plus oxaliplatin plus 5 fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carcinoma and extrahepatic metastasis: study protocol for a randomized controlled trial
9
<p>A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma</p>
10
PubMedCentral-PMC5616052.pdf
9
The best objective response of target lesions and the incidence of treatment related hypertension are associated with the survival of patients with metastatic renal cell carcinoma treated with sunitinib: a Japanese retrospective study
9
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
9
Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST
10
Usefulness of Pseudocontinuous Arterial Spin Labeling for the Assessment of Patients with Head and Neck Squamous Cell Carcinoma by Measuring Tumor Blood Flow in the Pretreatment and Early Treatment Period
7
Evaluation of therapeutic effect of tumor-targeted therapy
8
Phase I study with ONCOS-102 for the treatment of solid tumors – an evaluation of clinical response and exploratory analyses of immune markers
18
Evaluation of tumor response to cytokine induced killer cells therapy in malignant solid tumors
5
<p>Meta-analysis of comparing part-solid and pure-solid tumors in patients with clinical stage IA non-small-cell lung cancer in the eighth edition TNM classification</p>
11
Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
9
Targeting the PD-1 pathway in pediatric solid tumors and brain tumors
10
Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma.
9
Evaluation of tumor hypoxia and proliferation in canine spontaneous solid tumors
231
Mesenteric Fibromyoma Mimicking a Colon Tumor: A Diagnostic Dilemma
5